Previous reports showed that overexpression of CDCA7 predicts poor prognosis and tumor progression in human breast cancer, lung adenocarcinoma and lymphoma, colorectal cancer, and pancreatic diseases (29–33). The gene discussed is CDCA7; the disease is breast carcinoma.